When did DENALI THERAPEUTICS INC (DNLI) report earnings last quarter?
DENALI THERAPEUTICS INC (DNLI) last reported earnings on 2/26/2026.
DENALI THERAPEUTICS INC (DNLI) Earnings History & Surprises
NASDAQ:DNLI • US24823R1059
Current stock price
20.65 USD
+0.97 (+4.93%)
At close:
20.8 USD
+0.15 (+0.73%)
After Hours:
DNLI Earnings overview
Past quarterly earnings results for DENALI THERAPEUTICS INC (DNLI), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 4, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.74
- Revenue Estimate
- 431.154K
Last Reported
Most Recent- Release Date
- Feb 26, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.73
- EPS Surprise
- 3.82%
- Revenue Surprise
- -100.00%
Beat Rate
Last 8 Quarters 31%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.73 | -0.76 | 3.82% | -8.96% | 1.177M | -100.00% | - | |
| Q3 2025 | -0.74 | -0.77 | 3.50% | -17.46% | - | - | ||
| Q2 2025 | -0.72 | -0.73 | 1.88% | -22.03% | 6.599M | -100.00% | - | |
| Q1 2025 | -0.78 | -0.70 | -11.43% | - | 1.067M | -100.00% | - | |
| Q4 2024 | -0.67 | -0.82 | 18.24% | 22.09% | 10.914M | -100.00% | - | |
| Q3 2024 | -0.63 | -0.63 | -0.50% | 12.50% | 9.18M | -100.00% | -100.00% | |
| Q2 2024 | -0.59 | -0.70 | 15.61% | -145.38% | 15.803M | -100.00% | -100.00% | |
| Q1 2024 | -0.78 | -0.72 | -8.80% | 2.50% | 14.304M | -100.00% | -100.00% | |
| Q4 2023 | -0.86 | -0.82 | -4.84% | -14.67% | 8.532M | -100.00% | -100.00% | |
| Q3 2023 | -0.72 | -0.82 | 12.04% | 14.29% | 1.267M | 11.404M | -88.89% | -64.81% |
| Q2 2023 | 1.30 | -0.70 | 286.35% | 370.83% | 294.123M | 13.727M | 2,042.66% | 460.23% |
| Q1 2023 | -0.80 | -0.72 | -11.37% | -50.94% | 35.141M | 29.294M | 19.96% | -16.53% |
| Q4 2022 | -0.75 | -0.81 | 6.94% | -20.97% | 10.3M | 13.378M | -23.01% | -17.60% |
| Q3 2022 | -0.84 | -0.82 | -2.15% | -21.74% | 3.6M | 14.762M | -75.61% | -32.08% |
| Q2 2022 | -0.48 | -0.56 | 14.30% | 4.00% | 52.5M | 44.779M | 17.24% | 129.26% |
| Q1 2022 | -0.53 | -0.52 | -2.25% | 8.62% | 42.1M | 26.206M | 60.65% | 432.91% |
| Q4 2021 | -0.62 | -0.42 | -46.88% | -132.46% | 12.5M | 45.721M | -72.66% | -96.05% |
| Q3 2021 | -0.69 | -0.48 | -42.76% | -27.78% | 5.3M | 30.887M | -82.84% | -43.62% |
| Q2 2021 | -0.50 | -0.42 | -19.83% | 10.71% | 22.9M | 28.474M | -19.58% | 294.83% |
| Q1 2021 | -0.58 | -0.35 | -65.09% | -5.45% | 7.9M | 32.256M | -75.51% | 119.44% |
| Q4 2020 | 1.91 | 0.01 | 23,968.75% | - | 316.8M | 79.773M | 297.13% | - |
| Q3 2020 | -0.54 | 2.64 | -120.47% | - | 9.4M | 384.98M | -97.56% | - |
| Q2 2020 | -0.56 | -0.61 | 8.65% | - | 5.8M | 3.859M | 50.30% | - |
| Q1 2020 | -0.55 | -0.58 | 5.40% | - | 3.6M | 5.107M | -29.51% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
-0.56%
Max EPS beat (4)
3.82%
Min EPS beat (4)
-11.43%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, DNLI has beaten EPS estimates in 3 out of 4 releases
In the last 4 quarters, DNLI reported -0.6% below the EPS estimates on average.
Related analysis
DENALI THERAPEUTICS INC / DNLI Earnings FAQ
Can you provide information on whether DENALI THERAPEUTICS INC beat earnings estimates in the last quarter?
DENALI THERAPEUTICS INC (DNLI) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often DENALI THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, DENALI THERAPEUTICS INC (DNLI) has beaten EPS estimates in 3 out of 4 releases.